In various emerging bioinformatics and biotech technologies, such as applications relating to the development of pharmaceutical drugs or Web applications involving sequence processing, the definition and enforcement of legal protection strategies based on intellectual property portfolios hold increasingly high commercial value. This paper provides an overview of these intellectual property rights, with an emphasis on those connected with method protection, information distribution, and emerging bioinformatics standards.